Reports for LORAZEPAM
Ingredient
LORAZEPAM
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-LORAZEPAM | 2MG | TABLET | Resolved | 2022-06-30 | 2023-06-09 | 163915 |
| TEVA-LORAZEPAM | 2MG | TABLET | Resolved | 2022-12-08 | 2023-06-09 | 177526 |
| LORAZEPAM SUBLINGUAL | 0.5MG | TABLET | Resolved | 2023-02-03 | 2023-04-17 | 183599 |
| LORAZEPAM SUBLINGUAL | 0.5MG | TABLET | Resolved | 2023-05-11 | 2023-07-15 | 192270 |
| LORAZEPAM SUBLINGUAL | 1MG | TABLET | Resolved | 2017-06-26 | 2017-08-18 | 13975 |
| LORAZEPAM SUBLINGUAL | 1MG | TABLET | Resolved | 2021-09-09 | 2021-09-30 | 145410 |
| LORAZEPAM SUBLINGUAL | 1MG | TABLET | Resolved | 2023-02-28 | 2023-05-01 | 185682 |
| LORAZEPAM | 0.5MG | TABLET | Resolved | 2017-08-02 | 2020-02-27 | 17964 |
| LORAZEPAM | 1.0MG | TABLET | Resolved | 2021-03-18 | 2024-03-02 | 135885 |
| LORAZEPAM | 2.0MG | TABLET | Resolved | 2021-03-18 | 2024-03-02 | 135879 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| LORAZEPAM | Discontinued | 2020-02-27 | 2020-02-27 | 107347 | ||
| LORAZEPAM INJECTION USP | 2MG | SOLUTION | Discontinued | 2020-02-14 | 2020-03-12 | 106265 |
| PMS-LORAZEPAM | 0.5MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117717 |
| PMS-LORAZEPAM | 1MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117720 |
| APO-LORAZEPAM | 0.5MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60591 |
| APO-LORAZEPAM | 1MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60594 |
| LORAZEPAM | 1MG | TABLET | Discontinued | 2017-06-06 | 2017-06-07 | 11980 |
| LORAZEPAM | 2MG | TABLET | Discontinued | 2017-06-06 | 2017-06-07 | 11983 |
| LORAZEPAM | 2MG | TABLET | Discontinued | 2017-06-06 | 2017-06-07 | 11986 |
| LORAZEPAM | 0.5MG | TABLET | Reversed | 2017-03-14 | 2017-07-31 | 2430 |